Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CRHBP | P24387 | 2/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7109252 | 1.00 | LMNA (0.48) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL34344 | 0.89 | — | — | |
| SCHEMBL16197636 | 0.89 | LMNA (0.47) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL4068282 | 0.85 | — | — | |
| SCHEMBL4435964 | 0.82 | — | — | |
| Cyclohexane SCHEMBL6541885 | 0.81 | ALDH1A1 (0.41) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL25421945 | 0.80 | SMN1; SMN2 (0.50) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL453569 | 0.80 | SMN1; SMN2 (0.50) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL5519262 | 0.80 | SMN1; SMN2 (0.50) | LMNASMN1; SMN2CRHBPCRHR2HTT | |
| SCHEMBL22362228 | 0.79 | TTR (0.43) | LMNASMN1; SMN2CRHBPCRHR2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200075998-A1 | CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200075998-A1 | CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | CLK2, CLK4, CACNA2D3 | LMNA 1726/4885SMN1; SMN2 3935/4885CRHBP 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.